Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
NewNow you can listen to Fox News articles!
A new daily pill can provide a simpler, convenient way to reduce cholesterol and reduce heart attack and Risk of stroke.
An experimental medicine called Obicetrapib passed the clinical trial of Phase 3 at Monas University in Australia.
The trial included more than 2,500 people at the age of 65. Everyone was diagnosed with heart disease, or had genetically high cholesterol, the university’s press release said.
New Studies suggest that this cheap product may become key to reduce cholesterol
All participants received “maximum portable doses” Therapy that lowers cholesterol.
One group received Obicetrapib, and the other group took placebo while maintaining its existing cholesterol.
A new daily tablet can provide a simpler, convenient way to reduce cholesterol and reduce the risk of heart attack and stroke. (Istock)
After 12 weeks, participants take A new drug Shown by 32.6% decrease in LDL cholesterol and lipoprotein drop by 33.5% (A) (LP (A)), the release said.
The conclusions were presented last month at the European Congress of Atherosclerosis in the UK and were also published in the magazine “Medicine” of New England.
“We know that many people who are at high risk of heart attack or stroke do not receive low cholesterol levels, even on the best available therapies,” said Professor Stephen Nikols, director of the Victorian Heart University at the University of Monas and Victorian Cardiac Hospital.
“We know that many people who are at high risk of heart attack or stroke do not receive low cholesterol levels, even at the best procedures available.”
“Obicetrapib offers a new promising option – not only it reduced LDL cholesterol more than 30%but also we saw a decrease in LP (A), which is much more difficult to treat and associated with increasing The risk of heart disease“
Lipoprotein with low density (LDL), sometimes called “poor cholesterol”, is associated with the negative health effects when they are present in large numbers. (Istock)
Lipoprotein with low density (LDL), sometimes called “poor cholesterol”, is associated with the negative health effects when they are present in large numbers.
LDL can accumulate in the blood vessels and increase the risk of heart attack and stroke, the researchers warned.
Click here to get the Fox News app
Lipoprotein (a) or LP (a) is a protein that is known to significantly increase the chances of a heart attack when it is present in a high level in the blood.
Unlike LDL, LP (A) – Hereditary Factor that cannot be changed Healthy behavior Either medicine.
Lipoprotein (a) or LP (a) is a protein that is known to significantly increase the chances of a heart attack when it is present in a high level in the blood. (Istock)
The participants noted that Obicetrapib was recognized as “well tolerated”, the researchers said.
“It can become a valuable tool in the fight against heart disease,” Nichols added. “This is convenient, it is effective, and it can help close the space for patients who have ended with options.”
Click here to subscribe to our health newsletter
A study funded by Newamsterdam Pharma, developer Obicetrapib, which is founded in the Netherlands, had some restrictions, the researchers note.
The participants noted that Obicetrapib was recognized as “well tolerated”, the researchers said. (Istock)
For example, participants were not selected on the basis of high LP (A), meaning that the study did not determine how the drug affected those who have increased protein levels.
In addition, the study evaluated the LDL level changes but did not actually measure heart attack or stroke Results.
For additional health articles visit www.foxnews.com/health
Additional research Patients needed for longer periods of time and include more diverse cohorts, the researchers have recognized.
Fox News Digital addressed the researchers for additional comments.
